---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-002053"
form_type: "8-K"
ticker: "TELA"
cik: "0001561921"
company_name: "TELA Bio, Inc."
filed_at: "2023-01-09T23:59:59+00:00"
generated_at: "2026-06-20T17:49:13.868154+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# TELA Bio launches NIVIS Fibrillar Collagen Pack for surgical wound management

## Summary
- NIVIS is an absorbent matrix of Type I and Type III bovine collagen for moderately to heavily exudating wounds and minor bleeding.
- The product complements the OviTex portfolio and expands TELA's soft-tissue preservation offerings.
- Commercial launch follows an exclusive development and distribution partnership with Collagen Matrix, Inc. announced in April 2022.
- NIVIS is provided in particulate form to be molded and packed into wounds, facilitating contact with host tissue.
- Product targets general, plastic, and reconstructive surgery markets.

## SEC filing metadata
- accession: 0001104659-23-002053
- form_type: 8-K
- ticker: TELA
- cik: 0001561921
- company_name: TELA Bio, Inc.
- filed_at: 2023-01-09T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1561921/000110465923002053/0001104659-23-002053-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1561921/000110465923002053/tm232660d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-002053
- JSON: https://secwatch.observer/filing/0001104659-23-002053.json
- Plain text: https://secwatch.observer/filing/0001104659-23-002053.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.